Overall, insufficient IL-15 levels and decreased responsiveness of CD4+CD25+CD127dim/− Tregs to IL-15 signaling might contribute to the immune dysfunction in CHB patients with T2DM. This evidence concerns the gene CD4 and type 2 diabetes mellitus.